Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002122143 | SCV002392345 | likely benign | Bifunctional peroxisomal enzyme deficiency; Perrault syndrome | 2023-12-28 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004045868 | SCV004882644 | uncertain significance | Inborn genetic diseases | 2022-08-31 | criteria provided, single submitter | clinical testing | The c.1199A>G (p.N400S) alteration is located in exon 13 (coding exon 13) of the HSD17B4 gene. This alteration results from a A to G substitution at nucleotide position 1199, causing the asparagine (N) at amino acid position 400 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |